# Lactobacillus Reuteri DSM 17938 in Gut Microbiota Development in Infant Born by Caesarean Section

> **NCT03675048** · NA · COMPLETED · sponsor: **BioGaia AB** · enrollment: 97 (actual)

## Conditions studied

- Dysbiosis
- Prophylaxis

## Interventions

- **DIETARY_SUPPLEMENT:** BioGaia Protectis drops
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03675048
- **Lead sponsor:** BioGaia AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2020-10-05
- **Final completion:** 2020-12-15
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2021-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03675048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03675048, "Lactobacillus Reuteri DSM 17938 in Gut Microbiota Development in Infant Born by Caesarean Section". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03675048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*